BIOMAT Database Logo BIOMAT Database Logo

[The treatment of cardiac insufficiency with desacetyl-lanatoside C]. 1970

A R Rinaldi

UI MeSH Term Description Entries
D007799 Lanatosides Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. (From Martindale, The Extra Pharmacopoeia, 30th ed, p670) Digilanides
D004074 Digitoxin A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665) Coramedan,Digimed,Digimerck,Digitaline Nativelle,Digitoxin AWD,Digitoxin Bürger,Digitoxin Didier,Digitoxin-Philo,Digophton,AWD, Digitoxin,Bürger, Digitoxin,Didier, Digitoxin,Digitoxin Philo,Nativelle, Digitaline
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A R Rinaldi
[Infantile cardiac insufficiency of bronchopneumopathic origin. Treatment with desacetyl-lanatoside C].
September 1966, Minerva pediatrica,
A R Rinaldi
[ON THE USE OF DESACETYL-LANATOSIDE C IN THE TREATMENT OF CARDIAC INSUFFICIENCY].
October 1964, Gazzetta medica italiana,
A R Rinaldi
[Effectiveness of the use of desacetyl-lanatoside C in the treatment of cardiac insufficiency].
July 1970, Minerva cardioangiologica,
A R Rinaldi
[Treatment of childhood cardiac insufficiency with lanatoside C].
October 1955, Minerva pediatrica,
A R Rinaldi
[OBSERVATIONS ON THE ACTIVITY OF A NEW DIGITALIC PRODUCT (DESACETYL-LANATOSIDE C) IN THE TREATMENT OF CARDIAC INSUFFICIENCY].
December 1963, Minerva medica,
A R Rinaldi
[Clinical experiences with desacetyl-lanatoside-C].
August 1965, La Clinica terapeutica,
A R Rinaldi
[Treatment of cardiac insufficiency with simultaneously administered lanatoside C & scillaren].
December 1957, El Dia medico,
A R Rinaldi
[Clinical experience on Desacetyl-lanatoside C].
March 1967, Minerva cardioangiologica,
A R Rinaldi
[Desacetyl-lanatoside-C in heart diseases].
October 1965, Minerva cardioangiologica,
A R Rinaldi
[Lanatoside C therapy of cardiac insufficiency].
June 1952, Giornale di clinica medica,
Copied contents to your clipboard!